13.00
-
13.30

Welcome
Bertil Romner & Pelle Johnsson

08.15
-
09.45

Neurointensive care & Microdialysis
Chairs: Carl-Henrik Nordström & Urban Ungerstedt

Intracerebral microdialysis in clinical routine
- Carl-Henrik Nordström
Multimodal monitoring in the NICU: Experience from 400 microdialysis patients
- Urban Ungerstedt
Cerebral Microdialysis for Biomarker Monitoring in the Neuro-ICU
- Lars Hillered
Does increasing glutamine signal boosting metabolism in hard working astrocytes?
- Carolina Samuelsson
Clinical significance of serum S100B levels in neurointensive care
- Johan Undén

Cerebrovascular diseases
Chairs: Christian Foerch & Derk M Krieger

Astroglial proteins as biomarkers in stroke
- Christian Foerch
The future of non-invasive monitoring for ischemic brain disease
- Derk M Krieger
A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage
- Natacha Turck
Early elevation of serum GSTP and NDKA levels predict stroke events and outcome
- Natacha Turck
Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.
- Gunnar Andsberg
NR2 Peptide Assay for Assessment of Cerebral Ischemic Events
- Svetlana Dambinova

Proteomics & Genomics
Chairs: Niels Videndahl Olsen & Kevin Wang

Microarrays from research to clinic
- Finn Cilius
Geneticinfluences on outcome following acute neurological insults
- James Nicoll
Proteomic-based discovery of novel brain injury biomarkers and their validation using animal models
- Kevin Wang
Blood Pressure Response to Anesthesia: A Retrospective Analysis of the Impact of Genetic Polymorphism in the Renin-Angiotensin System, Adrenergic System and Nitric Oxide System
- Morten Nielsen
From cerebrospinal fluids to brain microdialysates: discovery of brain damage markers through quantitative proteomics
- Dayon Loïc
Risk of aneurysmal subarachnoid hemorrhage and genetic polymorphism in the nitric oxide synthase system
- Jonatan Myrup

08.15
-
09.45

Minor head injury
Chairs: Johan Undén & Bertil Romner

Initial management of mild head injury. What´s the problem?
- Johan Undén
S-100 as a routine parameter for patients suffering form MHT:
Prognostoc value, elimination kinetik and connection to postconcussion syndroms
- Peter Biberthaler
Rapid release of AMPA receptor (AMPAR) peptide correlates with concussion and mild traumatic brain injury (TBI)
- Svetlana Dambinova
Evaluation of serum S100B sampling in clinical head injury management
- Olga Calcagnile

Severe head injury
Chairs: Bo-Michael Bellander & Lars-Ove Koskinen

Challenges of TBI biomarker assay development and validation in human severe TBI study
- Kevin Wang
ApoE-epsilon4 allele influences the levels of S-100B and NSE in severe head injury
- Lars-Ove Koskinen
Neuron specific enolase and protein S100B as markers for brain damage after traumatic brain injury (TBI)
- Marjan Korsic
Does extracerebral trauma affect the predictive values of S100B regarding cerebral injuries?
- Søren Ohrt-Nissen
Temporal profiles in serum concentrations of S100B after traumatic brain injury inflict on outcome
- Bo-Michael Bellander

Pediatric issues
Chairs: Rachel Berger & Vineta Fellman

Searching for the Holy Grail: Biomarkers in Pediatric TBI
- Rachel Berger
Hypothermia treatment for the asphyxiated newborn infant
- Vineta Fellman
Role of targeted quantitative Metabolomics in biomarker discovery of perinatal brain injury
- David Enot
Serum and urine S-100B after traumatic head injury in children
- Magnus Hallén
Age and gender distribution of capillary and venous serum S100B among healthy children
- Ramona Åstrand

08.15
-
09.45

Brain imaging 2009
Chairs: Olaf B Paulson & Bertil Romner

Brain imaging - what can we expect in the coming decade?
- Olaf B Paulson
Imaging macro- and microstructural brain changes following severe head injury
- Annette Sidaros

Future Aspects
- Kevin Wang
- Tor Ingebrigtsen
- Roy Sherwood
- Rachel Berger